Skip to main content
$17.86 $0.11 (0.6%)

04:00 PM EDT on 10/21/21

Trillium Therapeutics Inc (NASDAQ:TRIL)

CAPS Rating: 3 out of 5

Current Price $17.86 Mkt Cap $2.3B
Open $17.75 P/E Ratio 0.00
Prev. Close $17.86 Div. (Yield) $0.00 (0.0%)
Daily Range $17.75 - $17.91 Volume 2,925,867
52-Wk Range $5.80 - $20.96 Avg. Daily Vol. 2,275,697

Caps

How do you think NASDAQ:TRIL will perform against the market?

Add Stock to CAPS Watchlist

All Players

39 Outperform
3 Underperform
 

All-Star Players

10 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:TRIL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

MJohannesmeyer (58.47)
Submitted August 19, 2021

SOOO cheap - it'll get bought out - perhaps by Pfizer who bought $25 Million in shares at about a 70% premium to today's stock price.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:TRIL VS S&P 500 (SPY)

NASDAQ:TRIL Summary

Recent Community Commentary

Read the most recent pitches from players about TRIL.

Recs

2
Member Avatar MJohannesmeyer (58.47) Submitted: 8/19/2021 12:49:23 PM : Outperform Start Price: $6.06 NASDAQ:TRIL Score: +192.01

SOOO cheap - it'll get bought out - perhaps by Pfizer who bought $25 Million in shares at about a 70% premium to today's stock price.

Recs

0
Member Avatar TMFbonefish (62.99) Submitted: 11/24/2020 11:44:02 AM : Outperform Start Price: $17.08 NASDAQ:TRIL Score: -20.51

I expect Trillium’s success to continue with positive results at this year’s ASH conference next month. With what management describes as “best in class monotherapy activity”, plenty of cash, and a competitor that was recently acquired for $5 billion, I expect more investors to realize the opportunity for Trillium Therapeutics justifies a market capitalization several times its current size.

Recs

0
Member Avatar FinFreedom2035 (< 20) Submitted: 6/15/2020 12:24:18 AM : Outperform Start Price: $7.42 NASDAQ:TRIL Score: +91.31

Best CD47 inhibitor drug.

Leaderboard

Find the members with the highest scoring picks in TRIL.

Score Leader

portefeuille

portefeuille (98.03) Score: +2,255.72

The Score Leader is the player with the highest score across all their picks in TRIL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
portefeuille2 98.99 4/29/2019 Outperform 5Y $0.70 +2,460.57% +54.57% +2,406.00 0 Comment
portefeuille 98.03 4/29/2019 Outperform 5Y $0.70 +2,460.57% +54.57% +2,406.00 0 Comment
odocoileus 58.66 1/22/2020 Outperform 5Y $2.97 +501.35% +36.58% +464.77 1 Comment
Paco57 65.32 1/24/2020 Outperform 5Y $3.59 +397.49% +36.53% +360.97 1 Comment
TMFGBudwell 65.66 2/28/2020 Outperform 5Y $3.49 +411.75% +57.33% +354.41 0 Comment
BOBBYLDc 64.82 4/10/2020 Outperform 5Y $4.25 +320.24% +63.44% +256.79 0 Comment
gunda7907 50.29 9/12/2017 Outperform 5Y $4.50 +296.89% +81.74% +215.14 0 Comment
Under5 69.81 4/27/2020 Outperform 5Y $4.97 +259.36% +59.09% +200.26 0 Comment
beecha 62.18 9/11/2017 Outperform 5Y $4.75 +276.00% +82.91% +193.09 0 Comment
MJohannesmeyer 58.47 8/19/2021 Outperform 5Y $6.06 +194.92% +2.91% +192.01 3 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TRIL.